MedTrace Logo

Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint

NCT02185222 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2020-11-04

No results posted yet for this study

Summary

As recommended allowance of oral vitamine D are unable to ensure the recommended serum concentration of vitamine D, the purpose of this study is to show that a dose of vitamin D3 higher than the recommended allowance may slow the cognitive decline of patients with a memory complaint.

Conditions

  • Memory Disorders
  • Age-Related Cognitive Decline

Interventions

DRUG

Cholecalciferol 100 000 UI

Study of superiority between Cholecalciferol high dose 100 000 UI versus placebo : one bulb per month during two years

DRUG

Placebo

Study of superiority between Cholecalciferol high dose 100 000 UI versus placebo : one bulb per month during two years

Sponsors & Collaborators

  • University Hospital, Tours

    lead OTHER

Principal Investigators

  • Fanny HENNEKINE, PH · CHRU TOURS - Hôpital Bretonneau

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-23
Primary Completion
2018-10-10
Completion
2018-10-10

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02185222 on ClinicalTrials.gov